000

HWAIL PHARM

No trades
See on Supercharts
Market capitalization
‪105.52 B‬KRW
‪3.86 B‬KRW
‪122.54 B‬KRW
‪36.76 M‬
Beta (1Y)
0.48

About HWAIL PHARM

Headquarters
Hwaseong
Employees (FY)
152
Website
Founded
1980
ISIN
KR7061250007
FIGI
BBG000MMK021
HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following businesses: Pharmaceutical Raw Material, Cephalosporin Antibiotic, Functional Health Food Ingredient. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory and others. The company was founded on November 18, 1980 and is headquartered in Hwaseong, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 061250 is 1601 KRW — it has increased by 0.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HWAIL PHARM stocks are traded under the ticker 061250.
HWAIL PHARM is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
061250 stock is 1.96% volatile and has beta coefficient of 0.48. Check out the list of the most volatile stocks — is HWAIL PHARM there?
Yes, you can track HWAIL PHARM financials in yearly and quarterly reports right on TradingView.
061250 stock has fallen by 0.68% compared to the previous week, the month change is a 5.49% fall, over the last year HWAIL PHARM has showed a 24.48% decrease.
061250 net income for the last quarter is ‪−1.82 B‬ KRW, while the quarter before that showed ‪3.65 B‬ KRW of net income which accounts for −149.89% change. Track more HWAIL PHARM financial stats to get the full picture.
Today HWAIL PHARM has the market capitalization of ‪102.71 B‬, it has decreased by 1.98% over the last week.
Like other stocks, 061250 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HWAIL PHARM stock right from TradingView charts — choose your broker and connect to your account.
061250 reached its all-time high on Aug 3, 2007 with the price of 6233 KRW, and its all-time low was 500 KRW and was reached on Jun 23, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 152.00 employees. See our rating of the largest employees — is HWAIL PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HWAIL PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HWAIL PHARM stock shows the sell signal. See more of HWAIL PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HWAIL PHARM EBITDA is ‪3.09 B‬ KRW, and current EBITDA margin is 2.52%. See more stats in HWAIL PHARM financial statements.